CytomX Therapeutics Statistics
Total Valuation
CTMX has a market cap or net worth of $78.90 million. The enterprise value is -$46.54 million.
Important Dates
The next confirmed earnings date is Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CTMX has 78.12 million shares outstanding. The number of shares has increased by 24.87% in one year.
| Shares Outstanding | 78.12M |
| Shares Change (YoY) | +24.87% |
| Shares Change (QoQ) | +2.72% |
| Owned by Insiders (%) | 1.02% |
| Owned by Institutions (%) | 58.93% |
| Float | 66.34M |
Valuation Ratios
The trailing PE ratio is 7.50.
| PE Ratio | 7.50 |
| Forward PE | n/a |
| PS Ratio | 0.70 |
| Forward PS | 1.15 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00
| Current Ratio | 1.00 |
| Quick Ratio | 0.98 |
| Debt / Equity | n/a |
| Debt / EBITDA | 1.03 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 1.94% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $980,074 |
| Profits Per Employee | $90,869 |
| Employee Count | 122 |
| Asset Turnover | 0.65 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CTMX has paid $3.99 million in taxes.
| Income Tax | 3.99M |
| Effective Tax Rate | 26.48% |
Stock Price Statistics
The stock price has decreased by -19.84% in the last 52 weeks. The beta is 1.06, so CTMX's price volatility has been similar to the market average.
| Beta (5Y) | 1.06 |
| 52-Week Price Change | -19.84% |
| 50-Day Moving Average | 1.15 |
| 200-Day Moving Average | 1.63 |
| Relative Strength Index (RSI) | 37.96 |
| Average Volume (20 Days) | 736,122 |
Short Selling Information
The latest short interest is 6.07 million, so 7.77% of the outstanding shares have been sold short.
| Short Interest | 6.07M |
| Short Previous Month | 6.25M |
| Short % of Shares Out | 7.77% |
| Short % of Float | 9.14% |
| Short Ratio (days to cover) | 8.41 |
Income Statement
In the last 12 months, CTMX had revenue of $119.57 million and earned $11.09 million in profits. Earnings per share was $0.13.
| Revenue | 119.57M |
| Gross Profit | 119.57M |
| Operating Income | 5.72M |
| Pretax Income | 15.08M |
| Net Income | 11.09M |
| EBITDA | 7.62M |
| EBIT | 5.72M |
| Earnings Per Share (EPS) | $0.13 |
Full Income StatementBalance Sheet
The company has $137.18 million in cash and $11.75 million in debt, giving a net cash position of $125.44 million or $1.61 per share.
| Cash & Cash Equivalents | 137.18M |
| Total Debt | 11.75M |
| Net Cash | 125.44M |
| Net Cash Per Share | $1.61 |
| Equity (Book Value) | -31.23M |
| Book Value Per Share | -0.40 |
| Working Capital | 222,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$85.80 million and capital expenditures -$486,000, giving a free cash flow of -$86.29 million.
| Operating Cash Flow | -85.80M |
| Capital Expenditures | -486,000 |
| Free Cash Flow | -86.29M |
| FCF Per Share | -$1.10 |
Full Cash Flow StatementMargins
Gross margin is 100.00%, with operating and profit margins of 4.79% and 9.27%.
| Gross Margin | 100.00% |
| Operating Margin | 4.79% |
| Pretax Margin | 12.61% |
| Profit Margin | 9.27% |
| EBITDA Margin | 6.37% |
| EBIT Margin | 4.79% |
| FCF Margin | -72.16% |
Dividends & Yields
CTMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.87% |
| Shareholder Yield | -24.87% |
| Earnings Yield | 14.05% |
| FCF Yield | -109.36% |
Analyst Forecast
The average price target for CTMX is $5.77, which is 471.29% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.77 |
| Price Target Difference | 471.29% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 0.87% |
| EPS Growth Forecast (5Y) | 60.30% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CTMX has an Altman Z-Score of -5.06 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.06 |
| Piotroski F-Score | 3 |